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PE and PPE proteins appear to be important for virulence and immunopathogenicity in mycobacteria, yet
the functions of the PE/PPE domains remain an enigma. To decipher the role of these domains, we have
characterized the triacylglycerol (TAG) hydrolase LipY from Mycobacterium tuberculosis, which is the only
known PE protein expressing an enzymatic activity. The overproduction of LipY in mycobacteria resulted in a
significant reduction in the pool of TAGs, consistent with the lipase activity of this enzyme. Unexpectedly, this
reduction was more pronounced in mycobacteria overexpressing LipY lacking the PE domain [LipY(PE)],
suggesting that the PE domain participates in the modulation of LipY activity. Interestingly, Mycobacterium
marinum contains a protein homologous to LipY, termed LipYmar, in which the PE domain is substituted by
a PPE domain. As for LipY, overexpression of LipYmar in Mycobacterium smegmatis significantly reduced the
TAG pool, and this was further pronounced when the PPE domain of LipYmar was removed. Fractionation
studies and Western blot analysis demonstrated that both LipY and LipY(PE) were mainly present in the
cell wall, indicating that the PE domain was not required for translocation to this site. Furthermore,
electron microscopy immunolabeling of LipY(PE) clearly showed a cell surface localization, thereby
suggesting that the lipase may interact with the host immune system. Accordingly, a strong humoral
response against LipY and LipY(PE) was observed in tuberculosis patients. Together, our results suggest
for the first time that both PE and PPE domains can share similar functional roles and that LipY
represents a novel immunodominant antigen.
The determination of the complete genome sequence of
Mycobacterium tuberculosis has provided crucial information
with respect to the physiology of this bacterium and the patho-
genesis of tuberculosis (TB) (16). One important outcome of
the genome-sequencing project was the discovery of two new
multigene families designated PE and PPE. About 10% of the
M. tuberculosis coding capacity (167 genes) is devoted to the
PE and PPE genes, named for the Pro-Glu (PE) and Pro-Pro-
Glu (PPE) motifs near the N terminus of their gene products
(16). In addition to these motifs, proteins of the PE family
share N-terminal domains of approximately 100 amino acids,
whereas the PPE proteins possess an N-terminal domain of
about 180 amino acids. Many PE and PPE proteins are com-
posed only of these homologous domains. However, other
members possess an additional C-terminal segment of variable
length, often composed of multiple copies of polymorphic GC-
rich sequences (PGRS), which led to the hypothesis that these
proteins have a structural role (9, 16). So far, no PE and PPE
genes have been identified in nonmycobacterial species. Be-
cause the PE and PPE gene families encode numerous pro-
teins in certain pathogenic mycobacterial species, including M.
tuberculosis and M. marinum, it is tempting to assume that they
fulfill important functions related to survival within different
environmental niches.
Some of the PE proteins may play a role in immune evasion
and antigenic variation (4, 9, 16, 20) or may be linked to
virulence (15, 27, 34). PPE proteins are also known to induce
a strong B-cell response in humans (13, 15, 44). Some of the
members of the PE and PPE families have been found to
associate with the cell wall (10, 21, 26, 30, 37). The PPE41-
encoding gene, Rv2430c, together with the PE25-encoding
gene, Rv2431c, have recently been found to be an operon (42).
The structure of the heterodimeric complex formed by PPE41
and PE25 has been determined, and it was shown that the PE
and PPE proteins mate along an extended apolar interface to
form a four--helix bundle, where two of the -helices are
contributed by the PE protein and two by the PPE protein (41).
These authors also proposed that some of the PE-PPE com-
plexes may be involved in signal transduction either as mem-
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brane-associated or soluble proteins, although this remains to
be clearly addressed. In general, although the PE and PPE
families of mycobacterial proteins are the focus of intense
research, no precise function has been unraveled for any mem-
ber of these families. Interpretation of the importance of the
PE and PPE domains is complicated by the paucity of poten-
tially functional data on PE/PPE members.
However, one PE protein, termed PE30 (11) and encoded by
Rv3097c, contains a carboxy-terminal polypeptide which ex-
presses triacylglycerol (TAG) hydrolase activity (19). The C-
terminal portion of PE30 (also designated LipY) is homolo-
gous to the hormone-sensitive lipase family characterized by
the conserved GDSAG active-site motif (19). Interestingly,
among the 24 M. tuberculosis putative lipases/esterases, LipY
induced the highest breakdown of stored TAGs under condi-
tions of starvation. In addition, TAG utilization was drastically
decreased under nutrient-deprived conditions in a lipY-defi-
cient mutant of M. tuberculosis. It was therefore proposed that
LipY may be responsible for the utilization of stored TAG
during dormancy and reactivation of the pathogen (19). There-
fore, LipY is interesting not only because it is the only PE
protein with a characterized enzymatic activity but also be-
cause it appears to be a key enzyme participating in mycobac-
terial dormancy.
We reasoned that because TAG hydrolysis can be easily
monitored in vivo, lipY could be used as a “reporter” gene and
would represent a powerful tool to scrutinize the contribution
of the PE domain to the lipase activity. Herein, we investigated
the role and effect of the PE domain on LipY activity in vivo
and analyzed the subcellular localization of the protein in
Mycobacterium bovis BCG. Finally, we analyzed the humoral
response to LipY in M. tuberculosis-infected patients.
MATERIALS AND METHODS
Strains and media. M. smegmatis mc2155 and M. bovis BCG 1173P2 cultures
were usually grown at 37°C under constant shaking in Sauton’s medium, in the
presence of either 50 g/ml hygromycin or 25 g/ml kanamycin when required.
Transformants were selected on Middlebrook 7H11 solid media supplemented
with oleic acid-albumin-dextrose-catalase enrichment (Difco) and containing
either 50 g/ml hygromycin or 25 g/ml kanamycin when necessary. Plates were
incubated at 37°C for 3 to 4 days for M. smegmatis and for about 15 days for M.
bovis BCG.
Plasmids and DNA manipulation. The Escherichia coli mycobacterial shuttle
vector pMV261 containing the hsp60 promoter was used as described previously
(40). The acetamide-inducible vector pSD26 (18) was used as reported earlier
(6). Restriction enzymes, T4 DNA ligase, and Vent DNA polymerase were
purchased from New England Biolabs. All DNA manipulations were performed
using standard protocols. For cloning of lipY and lipY(PE) in pMV261, the lipY
and lipY(PE) genes were amplified by PCR using M. tuberculosis H37Rv
genomic DNA and the following primers: upstream primers lipY-up 5-TGT CTT
ATG TTG TTG CG-3 and lipY(PE)-up 5-TCG CCA GCG GTA TCG GGA
ACG G-3 and the downstream primer lipY-lo 5-AAG GAT CCT CAG GCG
GCG ATA CCG AGT TGC TG-3 (contains a BamHI site [underlined]). Both
PCR products were cut with BamHI and directly ligated into pMV261 restricted
with MscI/BamHI. Cloning of lipY and lipY(PE) into pSD26 was performed by
amplifying the genes using the following primers: upstream primers pSDlipY-up
5-AAA GGA TCC GTG TCT TAT GTT GTT GCG TTG-3 and
pSDlipY(PE)-up 5-AAA GGA TCC TTC GCC AGC GGT ATC GGG AAC
GG-3, respectively, and the downstream primer pSDlipY-lo 5-AAG GAT CCG
GCG GCG ATA CCG AGT TGC TG-3 (all three primers contain BamHI sites
[underlined]). Both PCR products were cut with BamHI and directly ligated in
frame into pSD26 restricted with BamHI. A similar approach was used to clone
M. marinum lipY (lipYmar) and lipY(PPE)mar in pSD26 by using M. marinum M
strain genomic DNA and the following primers: upstream primers pSDmarlipY-up
5-AAG GAT CCA GTT TCT GGA TGT GGC CGC CC-3 and
pSDmarlipY(PPE)-up 5-AAG GAT CCT TCG CCC GAG CCC TGG ACA
ACG GTC-3, respectively, and the downstream primer pSDmarlipY-lo 5-AAG
GAT CCG GCC GCG ATG CCG AGT TCC TGG TTG ATC-3.
Site-directed mutagenesis of the S309 residue. A pMV261::lipY(PE) deriv-
ative containing the S309A point mutation within the lipY(PE) gene was gen-
erated by site-directed mutagenesis. pMV261::lipY(PE) was used as a template
for the QuikChange II site-directed mutagenesis kit (Stratagene) with the fol-
lowing primers: S309A-up 5-GCG TGG TCG GGG ACG CCG CGG GCG
GCA ACC-3 and S309A-lo 5-GGT TGC CGC CCG CGG CGT CCC CGA
CCA CGC-3 (the nucleotide changes that allow specific amino acid replacement
are indicated in bold). Mutant clones were verified by automated DNA sequenc-
ing.
Subcellular fractionation of mycobacteria. Cells were disrupted using a
French pressure cell and subcellular fractionation was performed essentially as
described previously (31). Briefly, cell lysates were centrifuged twice at 1,000 
g to remove unbroken cells and insoluble material. Lysate supernatants were
then centrifuged at 20,000 g at 4°C to separate the soluble cytoplasmic fraction
from the cell wall. The cell wall fraction was washed three times with phosphate-
buffered saline (PBS) in order to remove cytoplasmic contaminants. Both frac-
tions were resuspended in identical volumes of buffer.
Gel overlay assay. Tributyrin agar plates were obtained by dissolving tributyrin
agar (Fluka) in distilled water at a final concentration of 20 g/liter. After steril-
izing at 121°C for 15 min, 10 g/liter of tributyrin (Sigma) was added to the hot
agar and the medium was sonicated in a water bath sonicator for a few seconds
and stirred with a magnetic stirrer to obtain a homogenous emulsion before
being poured into plates. Recombinant transformants expressing lipase activity
were identified by their ability to form clear zones in an otherwise turbid and
yellowish medium. Lipase activity was also directly determined on crude myco-
bacterial lysates and/or cell wall preparations. Proteins were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under nonre-
ducing conditions. After electrophoresis, the gels were washed twice for 15 min
in 25% isopropanol and then twice for 5 min in 20 mM Tris-HCl, pH 8.0. The
gels were then laid on top of a tributyrin agar plate and incubated overnight at
room temperature (RT). A protein with lipolytic activity generates a clear halo
on plates.
In vitro lipase assay. Lipolytic activity was assayed using cell wall preparations
from M. smegmatis strains carrying the various lipase-expressing derivatives fol-
lowing induction with acetamide. Cell wall fractions from M. smegmatis harbor-
ing empty pSD26 was used as an internal control, so that the activity observed
can be attributed only to the overexpressed lipases. para-Nitrophenyl stearate
(Sigma) was used as the substrate, as it is specifically hydrolyzed by lipases and
not by carboxyl esterases, which can hydrolyze substrates with short-chain acyl
groups only (45). Assays were performed in 96-well plates (in a 100-l reaction
mixture) containing increasing cell wall concentrations and a final concentration
of 0.5 mM p-nitrophenylstearate (by diluting a 20 mM stock solution in aceto-
nitrile with 100 mM Tris-HCl, pH 8.0). The mixture was incubated at 35°C, and
the release of p-nitrophenol was measured spectrophotometrically at 405 nm
after 40 min of reaction. The lipase activity was expressed as the difference
between absorbance at 40 min and that at 0 min. Reactions were done in
triplicate.
Protein purification. Recombinant LipY and LipY(PE) were extracted from
cell wall preparations of acetamide-induced M. smegmatis cultures harboring
either pSD26::lipY or pSD26::lipY(PE). The proteins were purified using Ni-
nitrilotriacetic beads under denaturing conditions by solubilizing the cell wall
preparations in 8 M urea. Elution fractions were then further subjected to
preparative SDS-PAGE, and the bands corresponding to LipY or LipY(PE)
were recovered from the gel by electroelution. Recombinant His-tagged Rv1818c
protein was expressed in E. coli harboring pET15b-Rv1818c (20), kindly provided
by M. J. Brennan, and purified by nickel chromatography as reported previously
(20). The protein concentration was determined using the bicinchoninic acid
protein assay reagent kit (Pierce).
Preparation of anti-LipY(PE) antiserum. Purified recombinant LipY(PE)
produced in M. smegmatis was used to prepare anti-LipY(PE) immune sera.
Rats were injected four times with 25 g of antigen mixed with an equal volume
of adjuvant (monophosphoryl lipid A and trehalose dicorynomycolate; Sigma) at
days 1, 15, 30, and 60. Sera were collected at various time points after the last
injection, and the specificity of the antibodies was tested by Western blotting.
Electrophoresis and immunoblotting. Mycobacterial cultures (10 ml) were
harvested, and the cells were resuspended in 0.8 ml of PBS and disrupted using
a bead beater (MM301; Retsch). Protein concentrations in crude cell lysates
were determined using the bicinchoninic acid protein assay reagent kit (Pierce).
Equal amounts of protein (10 or 20 g) were then separated by 12% SDS-PAGE
and transferred onto a Protran nitrocellulose transfer membrane (Schleicher &
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Schuell). The membranes were then saturated with 1% bovine serum albumin
(BSA) in PBS, 0.1% Tween 20 and probed by incubation overnight with either
rat antiserum raised against LipY(PE) at a 1/2,500 dilution or rabbit anti-
OmpATb antiserum raised against the M. tuberculosis protein (38) at a 1/25,000
dilution. After extensive washing, the membranes were then incubated with
anti-rat or anti-rabbit immunoglobulin G (IgG) conjugated to alkaline phos-
phatase, respectively (dilution, 1/7,000; Promega). Monoclonal antibodies
against M. tuberculosis KatG (IgG1; clone IT-57) were also used at a 1/1,000
dilution and served as a marker for the detection of cytoplasmic contamination
in the cell wall fraction (35).
Labeling experiments and analysis of apolar lipids. Mycobacterial cultures
were grown in Sauton’s medium and labeled with 1 Ci/ml [1, 2-14C]acetate (50
to 62 mCi/mmol; Amersham) for 4 h (M. smegmatis) or 24 h (M. bovis BCG).
14C-labeled apolar lipids were then extracted by adding 2 ml of CH3OH:0.3%
NaCl (100:10) and 2 ml petroleum ether to the cell pellet. After centrifugation,
the upper petroleum ether layer was removed, and 2 ml of petroleum ether was
added. The combined petroleum ether extracts were then evaporated under
nitrogen to yield apolar lipids that were resuspended in CH2Cl2 prior to auto-
radiography–thin-layer chromatography (TLC) analysis. Total apolar lipids were
analyzed by two-dimensional (2D) TLC using silica gel plates (5735 silica gel
60F254; Merck, Darmstadt, Germany) as reported earlier (5) and as follows: first
dimension, petroleum ether-ethyl acetate (98:2; 3); second dimension, petro-
leum ether-acetone (98:2). To visualize free fatty acids, plates were resolved
using chloroform-methanol (96:4) in the first dimension and toluene-acetone
(80:20) in the second dimension. TLC plates were exposed overnight to Kodak
X-Omat film.
Electron microscopy (EM) immunolabeling of LipY(PE). M. bovis BCG
strains were grown at 37°C without any shaking. The immunolocalization of LipY
was performed on thin sections of cryosubstituted bacteria. In this case, bacteria
were fixed for 1 h at RT with a mixture of 2.5% paraformaldehyde and 0.1%
glutaraldehyde in 0.1 M phosphate (Sorensen) buffer, rapidly washed with buffer,
and postfixed at 4°C with 1% paraformaldehyde in the same buffer. After two
washes with 50 mM NH4Cl-containing buffer and three washes with NH4Cl-free
Sorensen buffer, bacteria were concentrated in 2% agarose in the same buffer.
Samples were then incubated in successive baths of 10%, 20%, and 30% sucrose
for 1 h each at 4°C and then overnight at 4°C in 2.3 M sucrose. Samples were then
frozen in ethane by the rapid plunging method and processed for cryosubstitu-
tion and embedding in Lowicryl HM20 as described previously (29). All immu-
nolabeling steps were carried out at RT. Thin sections of even thickness (70 nm)
were collected on nickel grids and sequentially incubated on drops of (i) PBS
containing 5% BSA and 0.1% Tween 20 for 15 min, (ii) rat anti-LipY(PE)
antibody for 2 h, (iii) rabbit anti-rat IgG (Dako) for 1 h, and (iv) protein A
coupled to gold particles of 5 nm in diameter (PAO) (University of Utrecht,
Utrecht, The Netherlands) for 30 min. Antibodies and PAO were diluted in PBS
containing 5% BSA and 0.1% Tween 20. In between the labelings and after
exposure to PAO, bacterial sections were washed with PBS containing 0.5% BSA
and 0.1% Tween 20. Sections were then washed with PBS only followed by
distilled water. Sections were then stained with uranyl acetate and lead citrate
prior to observation under the EM. The number of gold particles within the
cytoplasm or associated with the bacterial surface was determined for 50 (five
groups of 10) different longitudinal bacterial profiles observed at random. Re-
sults are expressed as means  standard errors of the means.
For a more precise surface localization of LipY, immunolabelings were per-
formed on whole bacteria either deposited onto EM Formvar-coated nickel grids
or kept in suspension. In the latter case, bacteria were either unfixed or fixed
prior to immunolabeling. The fixative consisted of 5% paraformaldehyde, EM
grade (Electron Microscopy Science), and 0.25% glutaraldehyde, EM grade
(Sigma), prepared in 0.1 M Na-cacodylate buffer, pH 7.2, containing 5 mM CaCl2
and 5 mM MgCl2. One volume of this fixative was added to an equal volume of
the bacterial suspension, and bacteria were fixed for 30 min at RT. All immu-
nolabeling steps were carried out at RT as described above. In the case of
bacteria on grids, the grids were sequentially deposited onto drops of antibodies
or washing medium. Bacteria kept in suspension were spun down at 10,000 rpm
for 5 min and resuspended in the successive antibodies, in PAO, or in washing
medium. As a control, bacteria were exposed to (i) preimmune rat serum instead
of anti-LipY(PE), (ii) rabbit anti-rat IgG and PAO only, or (iii) PAO only.
Antibodies and PAO were diluted in PBS containing 5% FBS. In between the
labelings and after exposure to PAO, bacteria were washed with PBS containing
0.5% FBS and then with PBS only. Bacteria on grids were then rinsed with
doubly distilled water, dried for 2 h at RT, and observed immediately under the
EM. Bacteria labeled in suspension were processed for conventional EM as
described below.
Processing for conventional EM. Bacteria were fixed for 2 h at RT with 2.5%
glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2, containing 5 mM CaCl2 and
5 mM MgCl2 and then washed twice with the same buffer and postfixed overnight
at RT with 1% osmium tetroxide in the same buffer. Following concentration in
1% agarose in the same buffer and treatment for 1 h at RT with 1% uranyl
acetate in Veronal buffer, bacteria were dehydrated in a graded series of ethanol
and embedded in Spurr resin. Thin sections were stained with uranyl acetate and
lead citrate. For quantifications, 200 to 600 different bacteria or bacterial profiles
were examined to determine the percentage of positively labeled bacteria.
Patients and control subjects. The study population (n  211) was comprised
of TB-infected patients reporting to the National JALMA Institute of Leprosy
and Other Mycobacterial Diseases in Agra, India. The patient population was
categorized into different clinical groups as follows. (i) Group 1 (n  94) con-
sisted of patients diagnosed with pulmonary TB for the first time and no history
of chemotherapeutic intervention. Group 1 had 69 adult and 25 child patients.
(ii) Group 2 (n  30) consisted of patients with relapsed infection, and all
recruited patients were adults. After diagnosis, these patients had a full course of
antitubercular chemotherapeutic treatment but had a recurrence of the infection
and disease symptoms after the therapy. Pulmonary TB in groups 1 and 2 was
confirmed by the presence of acid-fast bacilli in at least two initial sputum smear
examinations and the growth of bacilli in BACTEC cultures. (iii) Group 3 (n 
31) consisted of 9 adult and 22 child patients with extrapulmonary TB infections.
Members from group 3 were primarily abdominal TB and tubercular meningitis
patients. The diagnosis of extrapulmonary TB was carried out by histological
examination as well as with bacillus culture positivity in specimens obtained from
extrapulmonary sites. The patients were categorized as per the guidelines of
National TB Control Program, Central TB division, Government of India. The
age ranges for adult and child patients were from 18 to 60 years and from 2 to
15 years, respectively. Sera were separated from blood and kept at 	20°C until
used. The samples were obtained from all donors upon entry into the study, and
samples from human immunodeficiency virus-positive subjects were excluded
from the study. The healthy donors (n 56) included in the study were recruited
after radiological and clinical examination to exclude individuals with active TB.
Additionally, healthy donors included in the study were age and gender matched
to the different clinical groups. The included subjects had given written consent,
and the current study was carried out after approval from the institutional
bioethics committee.
Serological characterization of LipY, LipY(PE), and Rv1818c. Enzyme-
linked immunosorbent assays (ELISAs) were carried out with 96-well microtiter
plates (Nunc) by use of LipY and LipY(PE) proteins purified from recombi-
nant M. smegmatis strains and Rv1818c purified from recombinant E. coli. The
plates were incubated with proteins (1.25 g/ml) overnight at 4°C, followed by
three washes with PBS-Tween 20 (0.05%) buffer. After blocking with 3% BSA in
PBS, wells were incubated with human sera (1:400 dilution in blocking buffer) for
1 h at 37°C prior to washing with PBS-Tween 20. The serum dilutions were
selected following preliminary titration assays. Plates were then incubated with
anti-human antibodies conjugated to horseradish peroxidase (HRP) and devel-
oped with O-phenylenediamine tetrahydrochloride. The absorbance values were
measured at 492 nm in an ELISA reader.
Statistical analysis. Student’s t test was used for the analysis of statistical
significance (P values). The data from serological reactivities of different cate-
gories of patients were compared with the data from healthy controls. GraphPad
Quickcalcs (online t test calculator [http://www.graphpad.com/quickcalcs/ttest1
.cfm]) was used for this purpose. Only P values of 
0.05 were considered
significant.
RESULTS
Overexpression of LipY or LipY(PE) in M. smegmatis de-
creases the TAG pool. TAGs are major lipid storage molecules.
TAG accumulation is uncommon in prokaryotes but has been
reported for different bacteria belonging to the actinomycetes
genera (3), including Mycobacterium (22). We have recently
shown that TAGs increased significantly during growth, espe-
cially during the late log phase of growth of M. kansasii (25).
TAGs are also known to accumulate in M. tuberculosis cells
entering the nonreplicative state (17). These results suggest
that the production of TAGs is growth state dependent and
that the accumulation of these lipids in intracellular lipid in-
clusions (22) or within the cell wall (32) may be advantageous
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for mycobacteria in vivo and be relevant to survival during
dormancy.
The LipY protein, encoded by Rv3097c, can be dissected
into three domains; the N-terminal PE domain and the C-
terminal catalytic domain are interspersed by another domain
which has no similarity with domains in any other known pro-
teins (Fig. 1A). To date, LipY appears to be the only PE
protein with a predicted function. We took advantage of this
feature to analyze the effect of the PE domain on enzyme
activity. We first analyzed the lipolytic activity of LipY in M.
smegmatis overexpressing the lipY gene, which was placed un-
der the control of a strong acetamide-dependent inducible
promoter (18). A major band corresponding to LipY, which
was absent in the control strain (the lipY gene being absent
from M. smegmatis), was observed in crude lysates of M. smeg-
matis carrying pSD26::lipY following induction with acetamide
(data not shown). Cells were then fractionated to separate the
cytoplasmic compartment from the cell wall. Proteins from
each compartment were separated by SDS-PAGE and stained
with Coomassie blue. Figure 1B clearly shows that the majority
of LipY was present in the cell wall fraction. To analyze the
contribution of the N-terminal PE domain in the activity of
LipY, the lipY gene devoid of its PE-encoding segment was
cloned into the pSD26 to generate pSD26::lipY(PE). The
truncated LipY protein [LipY(PE)] was also readily detected
in the cell wall fraction (Fig. 1B).
FIG. 1. Expression of lipY in M. smegmatis and in vivo effect on TAG hydrolysis. (A) Schematic representation of LipY and LipY(PE) from
M. tuberculosis, LipYmar and LipY(PPE)mar from M. marinum, and the PE-PGRS protein Rv1818c. The conserved PE and PPE domains are
shown in gray, along with the Pro-Glu (PE) and Pro-Glu-Glu (PPE) signatures. The Gly-Ala-rich PGRS domain of Rv1818c is shown as a dot-filled
rectangle. The lipase domains of LipY and LipYmar are represented in black, whereas the adjacent domains (100 to 206 in LipY and 177 to 296
in LipYmar) with no homology to known sequences are shown in white. The catalytic lipolytic serine is represented in bold. (B) Mid-log-phase
cultures of M. smegmatis carrying either pSD26, pSD26::lipY, or pSD26::lipY(PE) were induced with 0.2% acetamide for 4 h. Cells were harvested
and fractionated to separate the cytosol (Cy) from the cell wall (CW). Equal protein amounts (50 g) were separated by 10% SDS-PAGE.
Positions of LipY and LipY(PE) are indicated by arrowheads. M, molecular mass marker. (C) M. smegmatis cultures were grown to mid-log phase
and induced with 0.2% acetamide for 4 h prior to labeling with 1 Ci/ml [1,2-14C]acetate for an additional 4 h. Apolar lipids were extracted as
described in Materials and Methods. Equal counts (250,000) were applied onto silica gel plates and separated using two different solvent systems:
solvent system A, which allows visualization of the TAGs (petroleum ether-ethyl acetate [98:2 {vol/vol}] in the first dimension [3] and petroleum
ether-acetone [98:2 {vol/vol}] in the second dimension), and solvent system C, which allows visualization of free fatty acids (chloroform-methanol
[96:4 {vol/vol}] in the first dimension and toluene-acetone [80:20 {vol/vol}] in the second dimension). TLC plates were exposed overnight to film.
The percentage of TAGs present in each strain (with regard to the reference strain presence, which was arbitrarily set to 100%) was determined
by densitometry and is indicated in the upper right corner of each TLC plate.
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To investigate whether the overexpression of LipY or
LipY(PE) influences TAG metabolism in M. smegmatis,
strains harboring either the empty plasmid, pSD26::lipY, or
pSD26::lipY(PE) were treated with acetamide for 4 h and
then labeled for an additional 4 h with 1 Ci/ml [1,2-14C]ac-
etate. Apolar lipids were then extracted, separated using dif-
ferent solvent systems, and analyzed by 2D TLC-autoradiog-
raphy (5, 25). Figure 1C, top, reflects TAG production in the
three mycobacterial strains. The overexpression of LipY was
accompanied by a significant reduction of the TAG pool
(about a 25% decrease with respect to the control strain),
indicating that LipY hydrolyzes TAGs in vivo. This reaction
was accompanied by a concomitant increase of the free fatty
acid ratio; free fatty acids are released by the hydrolyzed TAGs
(Fig. 1C, bottom). Unexpectedly, we found that the overex-
pression of LipY(PE) dramatically reduced the TAG pool in
the pSD26::lipY(PE) strain (70% reduction with respect to
the control strain). Consistently, the release of free fatty acids
was also found to be more pronounced in this latter strain.
Since LipY and LipY(PE) were expressed to comparable
amounts in the two recombinant strains (Fig. 1B), the en-
hanced lipolytic activity of the LipY(PE)-overexpressing
strain cannot be attributed to an increased LipY(PE) expres-
sion level. Together, these results suggest that, in vivo,
LipY(PE) hydrolyzes TAGs more efficiently than LipY.
Removal of the PPE domain of LipY from M. marinum
affects the enzyme activity in vivo. Analysis of the mycobacte-
rial genome databases allowed the identification of an ortho-
logue gene of lipY in Mycobacterium marinum. Surprisingly, a
BLAST search revealed that although the catalytic domain is
well conserved between M. marinum and M. tuberculosis, the
N-terminal domain of the M. marinum protein (named LipYmar)
showed no homologies with the PE domain of LipY but
instead showed strong homology with the PPE domain of dif-
ferent proteins. PPE genes are widely present in pathogenic
mycobacteria, such as M. marinum and M. avium (1, 27). As for
the function of PE proteins, that of PPE proteins remains an
enigma, although recent studies have suggested that they are
involved in virulence (27). Figure 1A represents the different
domains present in LipYmar. Because it contains a PPE do-
main of about 180 amino acids, the M. marinum protein is
longer than the M. tuberculosis protein. We reasoned that since
in one pathogenic strain the lipolytic activity is fused to a PE
domain and in another pathogenic strain the same activity is
fused to a PPE domain, this would give us a unique opportu-
nity to investigate/compare the roles of the PE and PPE do-
mains with respect to enzymatic activity. Therefore, the lipYmar
gene and the lipY(PPE)mar gene were cloned into pSD26, and
the resulting plasmids were introduced into M. smegmatis. Fig-
ure 2A shows that both LipYmar and LipY(PPE)mar are
highly expressed at the expected sizes after the addition of
acetamide to the culture medium. Western blot analysis using
the rat anti-LipY(PE) antiserum, which strongly cross-re-
acted with LipYmar and LipY(PPE)mar, showed that both
proteins were expressed at comparable levels (Fig. 2A), which
allowed us to analyze the influence of the PPE domain on the
FIG. 2. Lipolytic activity of LipYmar expressed in M. smegmatis. (A) Mid-log-phase cultures of M. smegmatis carrying either pSD26,
pSD26::lipYmar, or pSD26::lipY(PE)mar were induced with 0.2% acetamide for 4 h, centrifuged, resuspended in PBS, and lysed. Equal amounts
of total proteins (20 g) were separated by 10% SDS-PAGE. The gel was stained with Coomassie blue to reveal the presence of LipYmar or
LipY(PPE)mar. A comparison of the expression levels of LipYmar and LipY(PPE)mar was done following Western blot analysis. Proteins were
transferred to a nitrocellulose membrane, probed with rat anti-LipY(PE) antibodies, and then incubated with anti-rat antibodies conjugated to
alkaline phosphatase. (B) Cultures of M. smegmatis carrying either pSD26, pSD26::lipYmar, or pSD26::lipY(PE)mar were grown to mid-log phase
and induced with 0.2% acetamide for 4 h prior to labeling with 1 Ci/ml [1,2-14C]acetate for an additional 4 h. Apolar lipids were extracted and
equal counts were applied onto TLC plates. Separation was done using solvent system A and plates were exposed overnight to a film. The
percentage of TAGs present in each strain (with regard to the reference strain presence, which was arbitrarily set to 100%) was determined by
densitometry and is indicated in the upper right corner of each TLC plate.
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activity. The pool of TAG was significantly reduced in the
strain overexpressing LipYmar (around 25% decrease) (Fig.
2B). More importantly, removal of the PPE domain drastically
reduced the TAG pool in the strain harboring pSD26::lipY
(PPE)mar (about 65% decrease). This indicates that LipYmar
is an active enzyme involved in TAG hydrolysis and that its
activity was strongly increased following the removal of the
PPE domain, similar to what was seen relative to removal of
the PE domain in LipY. Together, these results suggest that
although they do not share sequence conservation, the PE and
PPE domains share similar function(s).
To confirm whether the removal of the PE/PPE domains
influences the lipolytic activity of LipY or LipYmar, we have
developed a cell-free assay using cell wall fractions from M.
smegmatis strains overproducing the lipases or their respective
truncated enzymes. Increasing concentrations of cell wall frac-
tions were incubated with para-nitrophenyl stearate, and the
lipolytic activity measured spectrophotometrically at 405 nm.
Cell wall fractions from M. smegmatis overexpressing
LipY(PE) were reproducibly found to be more active than
those from M. smegmatis overexpressing LipY in hydrolyzing
para-nitrophenyl stearate, whereas cell wall preparations from
FIG. 3. In vitro lipase assay. An in vitro assay was developed using cell wall fractions from M. smegmatis strains overproducing the various
lipases following induction with 0.2% acetamide. Cell wall preparations from M. smegmatis harboring empty pSD26 were used as an internal
control, so the activity observed can be attributed only to the overexpressed lipases. Western blot analysis of the cell wall fractions using
anti-LipY(PE) antibodies confirmed the presence of equal amounts of the overexpressed lipases. Increasing concentrations of cell wall fractions
(in micrograms) were incubated with para-nitrophenyl stearate at 35°C for 40 min. The release of para-nitrophenol was monitored spectropho-
tometrically at 405 nm. (A) Lipolytic activity of LipY versus LipY(PE) and (B) lipolytic activity of LipYmar versus LipY(PPE)mar. Each data
point is the mean of triplicates, and error bars correspond to standard deviation (). The data are representative of three experiments performed
with independent cell wall preparations.
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M. smegmatis harboring the empty vector did not express any
activity (Fig. 3A). Western blot analysis of the cell wall frac-
tions with anti-LipY(PE) antibodies confirmed the presence
of equivalent amounts of the overexpressed lipases, thus ruling
out the possibility that the differences in activity were due to
different expression levels of LipY and LipY(PE). Consistent
with these results, cell wall fractions from M. smegmatis over-
expressing LipY(PPE)mar exhibited an enhanced lipolytic ac-
tivity compared to those from M. smegmatis overexpressing
LipYmar (Fig. 3B).
Together, these results support the hypothesis that the PE/
PPE domains modulate the lipolytic activities of LipY and
LipYmar, respectively.
The lipase Ser309 residue is required for the reduction of
the TAG pool in M. bovis BCG. The lipY gene appears to be
restricted to members of the M. tuberculosis complex, whereas
the corresponding orthologue gene is a pseudogene in M.
leprae and is absent in M. smegmatis. We therefore chose to
overexpress the gene in M. bovis BCG. Both lipY and
lipY(PE) were placed under the control of the constitutive
hsp60 promoter in the pMV261 vector (40). Western blot anal-
ysis of the crude lysates of the recombinant M. bovis BCG
strains showed that comparable amounts of LipY and
LipY(PE) were expressed in strains carrying pMV261::lipY
and pMV261::lipY(PE), respectively (Fig. 4A). Interestingly,
LipY could not be detected in protein extracts of the control
strain, indicating that it is not expressed or is expressed only
poorly during normal in vitro growth conditions.
Following labeling with acetate, apolar lipids were extracted
and resolved by 2D TLC. Figure 4B shows a decreased inten-
sity of the spot corresponding to TAGs in the strain overpro-
ducing LipY, which was further decreased in the LipY(PE)-
overexpressing strain (about 60% decrease with respect to the
control strain). Since similar levels of LipY and LipY(PE) are
produced in these strains, the reduced pool of TAGs present in
the LipY(PE)-overexpressing strain cannot be attributed to
an excess LipY(PE) expression. Similar results were obtained
when the M. bovis BCG strains were labeled with [14C]stearate
(data not shown).
LipY possesses the conserved active-site motif GDSAG, a
characteristic motif of the hormone-sensitive lipase family that
contains an active serine residue (19). In addition, LipY and
LipY(PE) contain a domain adjacent to the catalytic domain
[residues 100 to 206 in LipY and 1 to 106 in LipY(PE)] (Fig.
1A) to which no functions have been assigned. We therefore
investigated whether the effect of TAG reduction could be
attributed to the presence of this domain or whether it was
directly linked to increased TAG hydrolase activity. To test this
hypothesis, we mutated the active Ser309 residue of the GDSAG
motif into an Ala residue. Autoradiography-TLC analysis
showed only a minor decrease in TAG biosynthesis (about 9%)
(Fig. 4B). The activity of the LipY(PE)(S309A) mutant was
directly examined using a gel overlay assay on tributyrin-con-
taining plates (Fig. 4C). A clear halo could be seen on the top
of the plates only with the M. bovis BCG strain overexpressing
LipY or LipY(PE), thereby indicating that both proteins
were able to use tributyrin as a substrate. However, no halo
formation was observed for the control strain or for the strain
overexpressing the S309A mutant protein, thereby indicating
that the Ser309 represents a crucial catalytic residue, as its
FIG. 4. Overexpression and lipolytic activity of LipY and LipY(PE) in M. bovis BCG. (A) lipY and lipY(PE), as well as a version of lipY(PE)
carrying the S309A mutation [encoding LipY(PE)(S309A)], were cloned in pMV261, and the resulting plasmids were introduced into M. bovis
BCG. The expression of the proteins in each lysate was assayed by Western blotting using rat anti-LipY(PE) antibodies. Equal protein amounts
(20 g) were separated on a 10% SDS-PAGE gel. (B) Recombinant M. bovis BCG cultures were labeled with 1 Ci/ml [1,2-14C]acetate for 24 h.
Apolar lipids were extracted and equal counts were applied onto silica gel plates. Separation was done using solvent system A and plates were
exposed overnight to film. The percentage of TAGs present in each strain (with regard to the reference strain presence, which was arbitrarily set
to 100%) was determined by densitometry and is indicated in the upper right corner of each TLC plate. (C) Gel overlay assay. M. bovis BCG lysates
were separated by SDS-PAGE. Following renaturation, the gel was laid on top of an agar plate containing tributyrin as a substrate. A clear halo
forms when the overexpressed lipase is active. Lanes: 1, M. bovis BCG pMV261; 2, M. bovis BCG pMV261::lipY; 3, M. bovis BCG
pMV261::lipY(PE)(S309A); 4, M. bovis BCG pMV261::lipY(PE).
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replacement abolished the enzyme activity. This is consistent
with the observation that the organophosphorous compound
E-600, known to irreversibly inhibit serine esterases/lipases,
completely blocked LipY activity at 0.5 M (19). Overall, these
results indicate that the reduction of the TAG pool is directly
correlated with the catalytic activity of the lipase.
The PE domain is not required to anchor LipY to the cell
wall. It has been suggested that the PE domain anchors the
protein to the cell wall, allowing the antigenically variable
PGRS domain of PE-PGRS proteins to gain access to the
extracellular compartment (4). The PE domain has been
shown to be required/essential for the cell wall localization of
another PE protein, Rv1818c (PE-PGRS33) (21). Our results
obtained with recombinant M. smegmatis strain suggest that
LipY is a cell wall-associated protein (Fig. 1). To confirm this
hypothesis, subcellular fractions of M. bovis BCG overproduc-
ing either LipY or LipY(PE) were probed with anti-
LipY(PE) antisera for the presence of these proteins. Con-
sistent with the results obtained for M. smegmatis, both LipY
and LipY(PE) were found to be present in the cell wall
fraction (Fig. 5A) and also in the cytosolic preparations. The
possible contamination of the cell wall fraction by cytoplasmic
components was ruled out by probing the fractions with mono-
clonal antibodies raised against the cytosolic catalase-peroxi-
dase KatG of M. tuberculosis (35). KatG was detected only in
the cytosolic fraction and not in the cell wall one, thereby
validating the purity of the cell wall preparations (Fig. 5A,
middle). Since OmpATb, the major porin from M. tuberculosis
and M. bovis BCG, has been shown to be associated with the
cell wall (2), it was used as a marker of the cell wall proteins.
Membranes were therefore probed with anti-OmpATb anti-
bodies. Figure 5A, bottom, clearly shows that the porin was
mainly present in the cell wall, although it could be detected in
the cytoplasmic fraction, as reported earlier (2). Altogether,
these fractionation studies establish that LipY and LipY(PE)
are present both in the cell wall and to a lesser extent in the
cytoplasm and that the PE domain is not required for cell wall
anchoring.
LipY and LipY(PE) are located in the outermost layer of
the M. bovis BCG cell wall. To confirm the location of
LipY(PE), immunolabelings were performed at the EM
level. Immunolabelings of thin sections of cryosubstituted bac-
teria with rat antibodies raised against LipY(PE) showed that
LipY was located both in the cytoplasm and at the bacterial
surface in M. bovis BCG overexpressing LipY (not shown) or
LipY(PE) (Fig. 5B). Thin sections of control M. bovis BCG
displayed lower amounts of intracytoplasmic gold particles
(5.9 1.3 versus 9.5 1.9) and, especially, three times fewer gold
particles on the bacterial surface (1.1  0.4 versus 3.4  1.0)
than seen for the LipY(PE) strain. More precisely, thin sec-
tions of control bacteria displayed between zero and three gold
particles at their surface, with 38.4% of the sections observed
displaying no gold particles. In contrast, LipY(PE)-overex-
pressing bacteria displayed between 0 and 12 gold particles at
their surface, with only 11.5% of the sections displaying no
gold particles and 34.6% of them displaying 5 particles or
more. Although we cannot completely exclude that some of the
gold particles might correspond to unspecific labeling, it is
clear that the strain overexpressing LipY(PE) is more
strongly labeled, especially at the bacterial surface.
These results are in agreement with those of the fraction-
ation studies which showed the presence of LipY or
LipY(PE) in both the cytoplasm and the cell wall. To confirm
the presence of LipY(PE) in the bacterial wall and gain
more-precise information on its location, additional experi-
ments were designed in such a way as to label only surface-
exposed LipY(PE). For such studies, it was therefore impor-
tant to grow bacteria in conditions where shedding of the outer
wall layer was kept minimal, i.e., without shaking of cultures
and also without bead shearing methods used to separate
FIG. 5. Localization of LipY and LipY(PE) in M. bovis BCG. (A) Subcellular localization of LipY and LipY(PE) in M. bovis BCG strains.
Cultures were lysed and fractionated to separate the cytoplasm (Cy) from the cell wall (CW). Equal amounts of proteins (10 g) of each fraction
were subjected to SDS-PAGE, electroblotted onto a nitrocellulose membrane, and probed with either rat anti-LipY(PE) antiserum (top),
monoclonal anti-KatG antibodies (middle), or rabbit anti-OmpATb antiserum (bottom). (B) EM immunolocalization of LipY. Thin sections of
cryosubstituted M. bovis BCG LipY(PE) were sequentially incubated on drops of (i) PBS containing 5% BSA and 0.1% Tween 20 for 15 min,
(ii) rat anti-LipY(PE) antibody for 2 h, (iii) rabbit anti-rat IgG for 1 h, and (iv) PAO for 30 min. Intracytoplasmic labeling is indicated by arrows
and surface labeling by arrowheads. Bar  0.5 m.
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clumps of bacteria. Two approaches were used, namely, im-
munolabeling (i) of whole bacteria deposited onto EM grids
for direct observation under the EM and (ii) of whole bacteria
in suspension prior to conventional processing for EM. With
the first method, the shedding of the outer layer of the wall is
minimal, as bacteria are never centrifuged, but nonspecific
binding of antibodies are more difficult to avoid, whereas when
the second approach is used, bacteria are submitted to several
FIG. 6. Immunolocalization of LipY(PE) at the surface of M. bovis BCG. Immunolabelings were performed on whole M. bovis BCG carrying
pMV261::lipY(PE), deposited on EM Formvar-coated nickel grids prior to labeling (A and B) or onto prefixed bacteria labeled in suspension prior to
processing for conventional EM (C to F). In both cases, bacteria were sequentially exposed to rat anti-LipY(PE) antibodies, rabbit anti-rat IgG, and
PAO. (A) Whole bacteria on grids exposed to specific antibody, followed by rabbit anti-rat IgG and PAO: the gold particles (300 to 400 per bacterium)
are distributed throughout the bacterial surface (arrows). (B) Whole bacteria on grids exposed to rabbit anti-rat IgG and PAO only as a control: bacteria
display at most 40 gold particles on their surface (arrow). (C to E) Thin sections of bacteria exposed to specific antibody, followed by rabbit anti-rat IgG
and PAO. (C) The outermost layer of the cell wall is labeled (arrow). This is particularly obvious in the enlarged view (D), where the peptidoglycan layer
(PG), the thin electron-translucent layer (ETL), and the outermost fibrillar layer (OL) are clearly visible. (E) When the OL has been shed, bacteria are
not labeled. (F) Thin sections of bacteria exposed to preimmune rat serum, followed by rabbit anti-rat IgG and PAO: bacteria are not labeled even when
the OL is present. Bars in panels A and B  0.5 m; Bars in panels C, E, and F  0.25 m; Bar in panel D  0.1 m.
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centrifugations, which can cause shedding of the outer layer. It
is noteworthy that the first method allows the labeling of a
given molecule on the entire bacterial surface, whereas the
second method shows labeling on a very small fraction of the
bacterial surface. The location of the molecule under study is,
however, more precise on thin sections. When the immunola-
belings were performed on EM grids, over 95% of the bacteria
were strongly labeled, with each bacterium displaying between
300 and 400 gold particles on its surface (Fig. 6A). If the
specific antibody was omitted, i.e., incubation with rabbit ant-
rat antibody followed by PAO only, bacteria displayed between
10 to 40 gold particles, indicating a low (less than 10%) back-
ground labeling due to unspecific binding of the secondary
antibody (Fig. 6B). Bacteria incubated with PAO only (not
shown) were completely negative. Labeling for LipY(PE) on
whole bacteria deposited onto grids clearly showed that the
lipase was surface exposed. When bacteria were immunola-
beled in suspension with antibodies raised against LipY(PE),
prior to fixation and processing for conventional EM, the cell
wall was labeled (Fig. 6C). On thin sections, the gold particles
were clearly restricted to the outermost fibrillar layer of the
wall, as shown in the enlarged view (Fig. 6D). Although bac-
teria had been slightly fixed prior to immunolabeling, shedding
of the outer layer proved to be unavoidable for about 80% of
the bacterial population. The surface of these bacteria dis-
played no gold particles (Fig. 6E). As a control, bacteria were
incubated with rat preimmune serum instead of rat antibodies
raised against LipY(PE). In this case, bacteria exhibiting an
outer layer were unlabeled (Fig. 6F). Together, these results
indicate that LipY, even when depleted for its PE domain, is
located in the outermost layer of the wall. Interestingly, bac-
teria were stained only when the outermost layer was present,
thereby indicating that more-interior layers of the wall do not
seem to contain the lipase.
Recombinant LipY and LipY(PE) display strong B-cell
responses during TB infection. Our results indicate that LipY
is strongly associated with the mycobacterial cell wall and more
precisely with the outermost layer. Thus, we hypothesized that
the protein may be accessible to the immune system of the
infected host. We therefore evaluated the role of LipY as an
antigen in a clinical setting. Experiments were designed to
evaluate the potential immune response of TB patients to
LipY and LipY(PE) that were expressed and purified from
recombinant M. smegmatis strains (Fig. 7A). Proteins were
used to screen the TB patient sera by ELISA, using anti-
human IgG-HRP and anti-human IgM-HRP as conjugates.
The humoral immune responses directed against LipY and
LipY(PE) by patients with TB and by healthy controls were
compared. As shown in Fig. 7B, sera from group 1 adult pa-
tients diagnosed with pulmonary TB mounted IgG and IgM
antibody responses against LipY significantly higher than those
from healthy controls. In addition, when assayed against puri-
FIG. 7. Specific anti-LipY humoral responses in M. tuberculosis-infected patients as opposed to healthy controls. (A) Purification of the
recombinant LipY and LipY(PE) proteins expressed in M. smegmatis carrying either pSD26::lipY or pSD26::lipY(PE). Proteins were extracted
from M. smegmatis cell wall preparations, excised from preparative polyacrylamide gels, and then electroeluted to obtain pure proteins. (B) ELISA
reactivities of IgG and IgM anti-LipY and anti-LipY(PE) antibodies were assayed in sera of either M. tuberculosis-infected group 1 adult patients
or healthy controls (HC) (n  44 for healthy controls; n  69 for patients). (C and D) ELISA reactivities of anti-LipY and anti-LipY(PE)
antibodies in two different categories of infected children. (C) IgG and IgM reactivities of sera from recently M. tuberculosis-infected children and
from healthy controls (n  12 for healthy controls; n  30 for patients). (D) IgG reactivities for patients with extrapulmonary TB (n  12 for
healthy controls; n  27 for patients).
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fied LipY(PE), these sera displayed IgG and IgM antibody
responses comparable to those obtained against LipY (Fig.
7B). This suggests that the humoral response elicited in pul-
monary TB adult patients is directly against the C-terminal
part of LipY (containing the catalytic domain) and not against
the N-terminal PE domain of the protein. We next assayed
sera from group 1 child patients against both LipY and
LipY(PE). The ELISA results show a strong IgG response
against both proteins that was significantly higher than that
seen for healthy controls (Fig. 7C). However, in contrast to
what was seen for adults, there were no significant differences
in the IgM responses in group 1 child patients (Fig. 7C). Fur-
thermore, both LipY and LipY(PE) exhibited significant IgG
but not IgM (data not shown) immunoreactivity with sera from
group 3 child patients with extrapulmonary TB infections (Fig.
7D). Since the M. tuberculosis genome encodes at least 24
putative esterases/lipases, one can hypothesize that the anti-
LipY-specific B-cell response elicited in TB patients may also
result from antibodies directed against other esterases/lipases
that are expressed during infection. However, this appears
unlikely, since LipY displays only 9 to 21% global amino acid
identity with the other M. tuberculosis lipases/esterases (19).
Taken together, these results indicate that LipY induces strong
B-cell responses in infected patients, pointing to the immuno-
dominant nature of the protein.
We next compared the serological sensitivities of LipY,
LipY(PE), and the PE-PGRS Rv1818c protein (Fig. 1A).
This last protein was chosen because it represents the most
widely studied PE-PGRS protein to date. Like LipY, Rv1818c
has been shown to be associated with the mycobacterial cell
surface (10, 21), and the immune response to this protein has
been reported earlier (20). The reactivities of 69 sera from TB
patients were assayed individually against LipY, LipY(PE),
and Rv1818c (Fig. 8). In most cases, the reactivities to LipY
and LipY(PE) were comparable, except for sera from pa-
tients 14 and 69, which presented much higher responses
against LipY than against LipY(PE). Conversely, sera from
patients 16, 36, and 44 exhibited higher titers against
LipY(PE) than against LipY. In general, poor ELISA reac-
tivity was observed against Rv1818c compared to LipY or
LipY(PE), with a few notable exceptions (sera 17, 24, 57, and
60).
DISCUSSION
There is an increasing body of evidence suggesting that fatty
acids represent a source of energy for pathogenic mycobacteria
during dormancy (17, 28, 36). Recently, it has been proposed
that M. tuberculosis stores fatty acids in the form of TAGs as it
enters in the nonreplicating persistence stage, similarly to hi-
bernating animals and microbial spores which use TAGs for
the long-term storage of energy (17). Utilization of the energy
stored in TAGs requires their hydrolysis and the release of free
fatty acids, which are subsequently catabolized by -oxidation.
In this study, we report that the overexpression of LipY in both
the saprophytic M. smegmatis and the slow-growing M. bovis
BCG species is accompanied by a significant decrease in the
TAG pool, which was almost completely restored when the
S309A mutation was introduced. This indicates that the de-
crease of TAGs was correlated with the expression of the TAG
hydrolase activity of LipY. Deb et al. (19) have reported that
among all the probable lipases present in M. tuberculosis, LipY
showed the highest capacity to hydrolyze long-chain TAGs
such as triolein. Our results indicate that LipY can hydrolyze
FIG. 8. Patient-by-patient analysis against LipY, LipY(PE), and Rv1818c. Sera from 69 M. tuberculosis-infected group 1 adult patients
(numbers below bars) were assayed individually by ELISA against LipY, LipY(PE), and Rv1818c.
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TAGs bearing a large panel of fatty acid chain lengths (ranging
from C4 to C18). Indeed, analysis of the fatty acid profile from
total TAGs purified from M. bovis BCG cultures harboring
either pMV261, pMV261::lipY, or pMV261::lipY(PE) did not
reveal major changes in terms of chain length specificity, al-
though the overall TAG content was dramatically reduced in
the LipY(PE)-overexpressing strain (data not shown). The
gel overlay assay also clearly demonstrated that LipY and
LipY(PE) can utilize tributyrin as a substrate. This suggests
that, in vivo, LipY has no selectivity for long fatty acyl chains,
since it also hydrolyzes TAGs bearing short-chain fatty acids.
The roles of the PE and PPE domains from the respective
M. tuberculosis and M. marinum LipY proteins with respect to
enzymatic activity were rather unexpected. The overexpression
of LipY and LipYmar lacking their respective PE and PPE
domains was accompanied by a substantial decrease of TAGs
in recombinant M. smegmatis strains. The role of the PE/PPE
domains in influencing the activity of the lipases was also
confirmed in in vitro assays using LipY and LipYmar lipases
lacking their respective PE and PPE domains. This is the first
study suggesting that PE and PPE domains can share similar
functions. One hypothesis is that the lack of the PE domain
could modify the network of interactions between LipY and
other PE/PPE-containing partners (41, 42) which could di-
rectly take part in the regulation of LipY activity. Interactions
of LipY with other PE/PPE partners could, for example,
dampen its activity. Such a hypothesis is consistent with the fact
that, in M. marinum, the PE domain has been replaced by a
PPE domain. However, more studies are needed to strengthen
this hypothesis.
An increasing body of evidence suggests that certain PE/PE-
PGRS proteins are found at the cell surfaces of mycobacteria
(9). Antisera raised against DNA vaccines expressing PE-
PGRS proteins recognize surface antigens on mycobacteria (4,
10). In addition, fluorescence microscopy of M. smegmatis ex-
pressing the PE-PGRS Rv1818c gene fused to enhanced green
fluorescent protein suggests that this protein is located on the
bacterial surface and that the PE domain is required for its cell
wall localization (21). According to previously published work,
the PE domain anchors the protein to the cell wall, allowing
the antigenically variable PGRS domain of PE-PGRS proteins
to gain access to the extracellular compartment (4). An impor-
tant message arising from our studies is that the PE/PPE do-
mains may not always be required for cell wall anchoring/
localization of the protein. It was recently shown that PPE41 is
a secreted protein in M. marinum and that secretion is depen-
dent on an ESAT-6-like-secretion system called ESX-5 (1).
Apart from ESX-4, all ESX regions have one or more PPE
genes (23), and it is possible that more PPEs are secreted via
the ESX-5 machinery. It is therefore possible that LipYmar is
translocated to the M. marinum cell wall through the ESX-5
machinery, a hypothesis that is further supported by the fact
that both LipYmar and the ESX-5 secretion system are specific
for pathogenic mycobacteria.
Our results are in agreement with a previous report showing
that LipY is the enzyme with the highest potential for hydro-
lyzing TAGs stored inside M. tuberculosis (19). Cell wall frac-
tionation studies and immunogold EM (Fig. 5 and 6) clearly
demonstrate that LipY is associated with the cell wall and
surface exposed, although the enzyme could be detected in the
cytoplasmic fraction of M. bovis BCG. The location of LipY is
therefore easy to reconcile with its activity, which consists of
hydrolyzing TAGs considered to be located within intracellular
lipid inclusions (22) and the mycobacterial cell wall (32) as
well. It is noteworthy that M. tuberculosis grown in vivo shows
a preference for fatty acids as the energy source, whereas it
prefers to utilize carbohydrates when growing in vitro (7). In
addition, macrophages infected with M. bovis BCG show a
marked reduction in the total amount of TAGs (24). Due to its
cell surface exposure and its accessibility to the host immune
system, LipY is a potential candidate for hydrolyzing host
macrophage TAGs, provided that this lipase manages to gain
access to the host’s lipids. This hypothesis is strengthened by
microarray analysis of the response of M. tuberculosis PE genes
to environmental changes which demonstrated that lipY was
induced at least twofold inside gamma interferon-activated
macrophages (43). Whether M. tuberculosis LipY is responsi-
ble for breakdown of host lipids during intracellular growth
remains, however, unknown at present.
Probing LipY expression by Western blotting of crude ly-
sates of M. bovis BCG grown in liquid culture did not reveal
the presence of the protein, thereby suggesting that it is not
expressed under these conditions or in amounts that are un-
detectable by this method. This is strengthened by a recent
transcriptome analysis indicating that the lipY gene in M. bovis
BCG (Mb3124c) is expressed at low levels (12). Similarly, the
lipase could not be detected in crude lysates of M. tuberculosis
H37Rv (data not shown). However, the induction of an impor-
tant specific B-cell response against LipY requires that the
antigen be expressed and properly presented to the immune
system. This suggests that lipY is a regulated gene, the expres-
sion of which is upregulated during the course of M. tubercu-
losis infection. This hypothesis is strongly supported by a recent
study aimed at identifying M. tuberculosis genes that are spe-
cifically upregulated in infected macrophages but not in in vitro
growth conditions (39). Among these genes, lipY was found to
be the most upregulated gene, and its expression was maximal
after 24 h of infection. This is particularly interesting since
studies with other pathogens have shown that genes which are
upregulated during infection are often important for pathoge-
nicity (14). Nevertheless, whether LipY expression may be
associated with disease manifestation and progression remains
to be addressed.
The lack of sufficient immune responses by TB patients
against several serodiagnostic M. tuberculosis antigens has been
emphasized. In many cases of patients with pulmonary TB, the
immune response to M. tuberculosis antigens is not sufficiently
primed to induce a potent humoral response. The surface-
exposed localization of an antigen is particularly suited for the
induction of a strong specific immune response. Here we show
for the first time that a mycobacterial lipase induces a potent
B-cell response in different clinical categories of TB patients
with pulmonary or extrapulmonary TB infections. In addition,
our results indicate that the immunogenic part of LipY is not
provided by the PE domain, since both LipY and LipY(PE)
elicited comparable IgG and IgM responses. This result is
consistent with earlier reports suggesting that the humoral
response to PE-PGRS antigens is directed against the PGRS
domain and not the PE domain. Studies with mice indicated
that following immunization with PE-PGRS DNA vaccine an-
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tibodies are produced only against the PGRS domain (20).
Overall, LipY appears to be a B-cell target antigen with ap-
parent diagnostic potential. To the best of our knowledge,
humoral responses elicited by bacterial lipases are rather un-
usual, although some recent reports have suggested that
lipases may be immunogenic proteins in Staphylococcus infec-
tions (8, 33). Therefore, LipY may provide an attractive can-
didate for future vaccine development in the form of recom-
binant M. bovis BCG expressing it alone or along with other
immunodominant antigens. In addition, because it is also up-
regulated and presumably important for pathogenicity/dor-
mancy, it may provide an attractive target for future drug
development.
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